Revance Therapeutics had a revenue of 59.88M in the quarter ending Sep 30, 2024, with -8.43%. This bring the company's revenue in the last twelve months to 247.00M, Decreased 1.27%. In the fiscal year ending Dec 31, 2023, Revance Therapeutics had annual revenue of 234.04M with 76.55% growth.